Colon Cancer Screening and the End of Life: Is Age Just a Number?

Author:

Reinink Andrew R.12,Malhotra Ashish34,Shaukat Aasma35

Affiliation:

1. Minneapolis VA Medical Center, Minneapolis, Minnesota, USA;

2. Division of Gastroenterology, Hepatology, and Nutrition, University of Minnesota School of Medicine, Minneapolis, Minnesota, USA;

3. Division of Gastroenterology and Hepatology, NYU Grossman School of Medicine, New York City, New York, USA;

4. Clinical Resource Hub, VISN 2, Department of Veterans Affairs, New York, New York, USA;

5. NY Harbor VA Medical Center, New York, New York, USA.

Abstract

Age is the strongest risk factor for colorectal cancer. Although there is updated guidance for the age at which to start screening, there is little guidance for individuals or their medical teams on how to decide when to stop. Current recommendations from the US Preventive Services Task Force and other societies focus primarily on age. For patients older than 85 years, guidelines discourage screening because the harms largely outweigh benefits. Although at a population level, the overall benefit of screening in older individuals decreases, one must individualize the recommendation based on comorbidities, functional status, screening history, and gender—not solely base it on age. Patient and caregiver preferences must also be thoroughly explored. Current models struggle with incorporating other colorectal cancer risk factors such as family history, previous adenomas, and modality of previous screening into recommendations and simulations, but are likely to improve with machine learning and whole electronic health record prediction-based approaches.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Gastroenterology,Hepatology

Reference13 articles.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Colorectal Cancer Screening Receipt Does Not Differ by 10-Year Mortality Risk Among Older Adults;American Journal of Gastroenterology;2023-10-27

2. Exploring GI Diseases Across the Lifespan;American Journal of Gastroenterology;2022-12-23

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3